Elisa Fumolo

发表

PNPLA3 rs738409C/G polymorphism in cirrhosis: relationship with the aetiology of liver disease and hepatocellular carcinoma occurrence

M. Pirisi, C. Fabris, E. Falleti, 2011, Liver international : official journal of the International Association for the Study of the Liver.

Risk factors for hepatocellular carcinoma recurrence after liver transplantation

D. Bitetto, E. Fornasiere, Elisa Fumolo, 2020, Hepatoma Research.

Liver Transplantation in Patients with Hepatocellular Carcinoma beyond the Milan Criteria: A Comprehensive Review

D. Bitetto, E. Fornasiere, Elisa Fumolo, 2021, Journal of clinical medicine.

Low risk of nosocomial severe acute respiratory syndrome-coronavirus-2 infection in patients with liver disease admitted to a hepatology unit at an academic hospital: A single-center experience

C. Fabris, E. Falleti, S. Cmet, 2022, Indian Journal of Gastroenterology.

Vitamin D and the risk of acute allograft rejection following human liver transplantation

M. Pirisi, C. Fabris, E. Falleti, 2010, Liver international : official journal of the International Association for the Study of the Liver.

An Essential Guide for Managing Post-Liver Transplant Patients: What Primary Care Physicians Should Know.

P. Burra, D. Bitetto, E. Fornasiere, 2021, The American journal of medicine.

D. Pinato, M. Pirisi, C. Fabris, 2010, Inflammation.

Prevalence and risk factors for delayed adrenal insufficiency after liver transplantation

M. Pirisi, C. Fabris, E. Falleti, 2008, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Recurrent and Treatment-Unresponsive Spontaneous Bacterial Peritonitis Worsens survival in Decompensated Liver Cirrhosis.

C. Fabris, E. Falleti, S. Cmet, 2020, Journal of clinical and experimental hepatology.

Challenges and future developments in liver transplantation.

D. Bitetto, E. Fornasiere, Elisa Fumolo, 2019, Minerva gastroenterologica e dietologica.

R-1626, a specific oral NS5B polymerase inhibitor of hepatitis C virus.

M. Pirisi, C. Fabris, D. Bitetto, 2008, IDrugs : the investigational drugs journal.

Occult hepatitis B virus infection in liver transplant recipients with recurrent hepatitis C: relationship with donor age and fibrosis progression

C. Avellini, M. Pirisi, C. Fabris, 2009, Clinical transplantation.

Vitamin D receptor gene polymorphisms and hepatocellular carcinoma in alcoholic cirrhosis.

M. Pirisi, C. Fabris, E. Falleti, 2010, World journal of gastroenterology.

IL-28B rs12979860 C/T allele distribution in patients with liver cirrhosis: role in the course of chronic viral hepatitis and the development of HCC.

M. Pirisi, C. Fabris, E. Falleti, 2011, Journal of hepatology.

Interleukin 6 promoter polymorphisms influence the outcome of chronic hepatitis C

M. Pirisi, C. Fabris, E. Falleti, 2010, Immunogenetics.

Vitamin D supplementation improves response to antiviral treatment for recurrent hepatitis C

M. Pirisi, C. Fabris, E. Falleti, 2011, Transplant international : official journal of the European Society for Organ Transplantation.

Interleukin-6 Polymorphisms and Gender: Relationship with the Occurrence of Hepatocellular Carcinoma in Patients with End-Stage Liver Disease

D. Pinato, M. Pirisi, C. Fabris, 2009, Oncology.

Low risk of nosocomial severe acute respiratory syndrome-coronavirus-2 infection in patients with liver disease admitted to a hepatology unit at an academic hospital: A single-center experience

C. Fabris, E. Falleti, S. Cmet, 2022, Indian Journal of Gastroenterology.

Immunogenicity and safety of a third dose of anti‐SARS‐CoV‐2 BNT16b2 vaccine in liver transplant recipients

C. Fabris, E. Falleti, M. Fabris, 2022, Liver international : official journal of the International Association for the Study of the Liver.

Past COVID-19 and immunosuppressive regimens affect the long-term response to anti-SARS-CoV-2 vaccination in liver transplant recipients

C. Fabris, E. Falleti, A. Sartor, 2022, Journal of Hepatology.

Role of Interleukin 28B rs12979860 C/T Polymorphism on the Histological Outcome of Chronic Hepatitis C: Relationship with Gender and Viral Genotype

M. Pirisi, C. Fabris, E. Falleti, 2011, Journal of Clinical Immunology.

MTHFR C677T polymorphism and risk of HCC in patients with liver cirrhosis: role of male gender and alcohol consumption.

C. Avellini, M. Pirisi, C. Fabris, 2009, Alcoholism, clinical and experimental research.

Antiviral treatment in patients with hepatitis C virus-related cirrhosis awaiting liver transplantation

M. Pirisi, C. Fabris, D. Bitetto, 2008, Therapeutics and clinical risk management.

Mycophenolate Interruption Restores Anti-SARS-CoV-2 Vaccine Immunogenicity in Unresponsive Liver Transplant Recipients

E. Falleti, M. Fabris, S. Cmet, 2023, Vaccines.

1155 IINTERLEUKIN 28B RS12979860 C/T POLYMORPHISM AND SERUM CHOLESTEROL AS PREDICTORS OF FIBROSIS PROGRESSION IN PATIENTS WITH CHRONIC HEPATITIS C AND PERSISTENTLY NORMAL TRANSAMINASES

M. Pirisi, C. Fabris, E. Falleti, 2011 .

Sarcoidosis or foreign‐body granulomatous reaction during interferon treatment?

C. Fabris, D. Bitetto, Elisa Fumolo, 2010, Liver international : official journal of the International Association for the Study of the Liver.

Baseline Predictors of the Long-Term Insufficient Biochemical Response in Patients with Autoimmune Hepatitis: A Single Center Experience

C. di Loreto, E. Falleti, S. Cmet, 2023, Journal of clinical medicine.

Vitamin D and the risk of acute allograft rejection following human liver transplantation

M. Pirisi, C. Fabris, E. Falleti, 2010, Liver international : official journal of the International Association for the Study of the Liver.